|
PICALM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.029700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.550450E-01 |
| Normal-vs-Stage2 |
9.329600E-01 |
| Normal-vs-Stage3 |
5.625600E-04 |
| Normal-vs-Stage4 |
9.763000E-03 |
| Stage1-vs-Stage2 |
5.951200E-01 |
| Stage1-vs-Stage3 |
6.362200E-03 |
| Stage1-vs-Stage4 |
8.191700E-02 |
| Stage2-vs-Stage3 |
1.068010E-01 |
| Stage2-vs-Stage4 |
1.941180E-01 |
| Stage3-vs-Stage4 |
5.801200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.694300E-02 |
| Normal-vs-AfricanAmerican |
1.377030E-04 |
| Normal-vs-Asian |
6.686600E-01 |
| Caucasian-vs-AfricanAmerican |
4.800300E-03 |
| Caucasian-vs-Asian |
8.308800E-01 |
| AfricanAmerican-vs-Asian |
1.503180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.663800E-03 |
| Normal-vs-Female |
1.804370E-01 |
| Male-vs-Female |
1.627570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.164400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.093200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.262000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.977200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.653800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.241400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.957600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.626100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.086200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.757600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.935000E-01 |
| Normal-vs-Grade 2 |
6.781800E-01 |
| Normal-vs-Grade 3 |
1.260370E-03 |
| Normal-vs-Grade 4 |
5.7570999999923E-05 |
| Grade 1-vs-Grade 2 |
6.052000E-01 |
| Grade 1-vs-Grade 3 |
6.688300E-02 |
| Grade 1-vs-Grade 4 |
1.440500E-02 |
| Grade 2-vs-Grade 3 |
1.402840E-03 |
| Grade 2-vs-Grade 4 |
9.93459999999446E-05 |
| Grade 3-vs-Grade 4 |
9.481600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.794000E-01 |
| Normal-vs-ccB subtype |
5.385700E-02 |
| ccA subtype-vs-ccB subtype |
7.848100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.165410E-01 |
| Normal-vs-N1 |
3.716800E-01 |
| N0-vs-N1 |
7.586400E-01 |
|
|
